Loading
Latest filing published 07 Jun 2022 for NexImmune, Inc..
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Grant Verstandig is a declared insider at 2 companies (board member); the most frequent names are NexImmune, Inc. and NexImmune, Inc. In total, 11 filings cover trades dated from 17 February 2021 to 7 June 2022.
On the market, this insider has only ever bought: 10 purchases, €3.6M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2022 alone, the filings show 9 purchases and no sales.
Half of the purchases are above €89k and half below. Clusters matter here: 10 out of 10 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 7 June 2022 came the latest disclosure, an open-market purchase for €31k in NexImmune, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations